Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection

BACKGROUND: In kidney transplantation, immunotherapy with thymoglobulin (rATG) has been used to down-regulate the patient immune system. rATG is a powerful immunobiologic drug used to deplete lymphocytes to prevent early acute rejection. The aim of this research was to evaluate the effects of immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasmar, Marcus Faria, Dutra, Rodrigo Santana, Nogueira-Machado, José Augusto, Fabreti-Oliveira, Raquel A., Siqueira, Raquel Gomes, Nascimento, Evaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693276/
https://www.ncbi.nlm.nih.gov/pubmed/31409321
http://dx.doi.org/10.1186/s12882-019-1497-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693276/
https://www.ncbi.nlm.nih.gov/pubmed/31409321
http://dx.doi.org/10.1186/s12882-019-1497-5

Ejemplares similares